{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:42:08Z","timestamp":1791200528719,"version":"4.2.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jash.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T14:01:19Z","timestamp":1372168879000},"page":"454-466","source":"Crossref","is-referenced-by-count":22,"title":["Effects of low-dose thiazide diuretics on fasting plasma glucose and serum potassium\u2013a meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"given":"Bertrand N.","family":"Mukete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Rosendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2013.05.004_bib1","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2013.05.004_bib2","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (allhat)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2013.05.004_bib3","first-page":"1","article-title":"Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008","author":"Yoon","year":"2010","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jash.2013.05.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000167045","article-title":"Problems with the use of diuretics in the treatment of hypertension","volume":"6","author":"Kaplan","year":"1986","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jash.2013.05.004_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/HYPERTENSIONAHA.109.142620","article-title":"Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity","volume":"55","author":"Manrique","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.05.004_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","article-title":"Thiazide diuretics, potassium, and the development of diabetes: a quantitative review","volume":"48","author":"Zillich","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.05.004_bib7","first-page":"539","article-title":"Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension","volume":"2","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.05.004_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.0954-6820.1976.tb06770.x","article-title":"Antihypertensive effect and side-effects of bendroflumethiazide and propranolol","volume":"199","author":"Berglund","year":"1976","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jash.2013.05.004_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(85)91900-2","article-title":"Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion","volume":"1","author":"Dornhorst","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.05.004_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2753.2011.01640.x","article-title":"Evaluation of the agreement between guidelines and initial antihypertensive drug treatment using a national health care reimbursement database","volume":"18","author":"Meneton","year":"2012","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.jash.2013.05.004_bib11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2010.07.053","article-title":"Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials","volume":"57","author":"Messerli","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jash.2013.05.004_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCULATIONAHA.108.828897","article-title":"Antihypertensive efficacy of aliskiren: is hydrochlorothiazide an appropriate benchmark?","volume":"119","author":"Messerli","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2013.05.004_bib13","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"key":"10.1016\/j.jash.2013.05.004_bib14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jash.2013.05.004_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jash.2013.05.004_bib16","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jash.2013.05.004_bib17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jash.2013.05.004_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1086\/268752","article-title":"RRT meets RDD: statistical strategies for assuring response privacy in telephone surveys","volume":"46","author":"Orwin","year":"1983","journal-title":"Public Opin Q"},{"key":"10.1016\/j.jash.2013.05.004_bib19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(81)92624-6","article-title":"Beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects","volume":"1","author":"Berglund","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.05.004_bib20","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1751-7176.2008.00054.x","article-title":"Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome","volume":"10","author":"Zappe","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jash.2013.05.004_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.158.7.741","volume":"158","author":"Savage","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2013.05.004_bib22","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1185\/03007990802118071","article-title":"Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study","volume":"24","author":"Pareek","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jash.2013.05.004_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/jhh.2010.3","article-title":"A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome","volume":"24","author":"Racine","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jash.2013.05.004_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jama.1987.03400040082026","article-title":"Efficacy and reduced metabolic side effects of a 15-mg chlorthalidone formulation in the treatment of mild hypertension. A multicenter study","volume":"258","author":"Vardan","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2013.05.004_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/jhh.2010.104","article-title":"Olmesartan\/amlodipine vs olmesartan\/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study","volume":"25","author":"Martinez-Martin","year":"2011","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jash.2013.05.004_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archinte.1994.00420070047005","article-title":"Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-hydrochlorothiazide group","volume":"154","author":"Chrysant","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2013.05.004_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2010.02.046","article-title":"Cardiovascular events during differing hypertension therapies in patients with diabetes","volume":"56","author":"Weber","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jash.2013.05.004_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.05.004_bib29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.tips.2011.07.006","article-title":"The renin-angiotensin-aldosterone system and glucose homeostasis","volume":"32","author":"Luther","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jash.2013.05.004_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2337\/diab.32.2.106","article-title":"Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium","volume":"32","author":"Helderman","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.jash.2013.05.004_bib31","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/archinte.166.20.2191","volume":"166","author":"Barzilay","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2013.05.004_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amjcard.2004.08.059","article-title":"Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes","volume":"95","author":"Kostis","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2013.05.004_bib33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0002-9149(94)90362-X","article-title":"The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham heart study)","volume":"74","author":"Tsuji","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2013.05.004_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/08037051.2011.649537","article-title":"The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium","volume":"21","author":"Okin","year":"2012","journal-title":"Blood Press"},{"key":"10.1016\/j.jash.2013.05.004_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1399-3054.2007.01033.x","article-title":"Beneficial effects of potassium on human health","volume":"133","author":"He","year":"2008","journal-title":"Physiol Plant"},{"key":"10.1016\/j.jash.2013.05.004_bib36","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.1997.03540440058033","article-title":"Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials","volume":"277","author":"Whelton","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2013.05.004_bib37","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1982.03330120023025","article-title":"Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group","volume":"248","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2013.05.004_bib38","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1056\/NEJM199406303302603","article-title":"Diuretic therapy for hypertension and the risk of primary cardiac arrest","volume":"330","author":"Siscovick","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2013.05.004_bib39","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199104183241605","article-title":"Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension","volume":"324","author":"Alderman","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2013.05.004_bib40","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.HYP.35.5.1025","article-title":"Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program","volume":"35","author":"Franse","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.05.004_bib41","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.35.5.1031","article-title":"Diuretic treatment of systolic hypertension in the elderly","volume":"35","author":"Schrier","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.05.004_bib42","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/j.1755-5922.2010.00258.x","article-title":"Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"30","author":"Raebel","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jash.2013.05.004_bib43","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1980.03310220049028","article-title":"Hyperkalemia resulting from captopril administration","volume":"244","author":"Warren","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2013.05.004_bib44","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2013.05.004_bib45","first-page":"547","article-title":"A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers","volume":"5","author":"Sadjadi","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jash.2013.05.004_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1527-5299.2000.80157.x","article-title":"Differential effects of direct antagonism of aii compared to ace inhibitors on serum potassium levels and azotemia in patients with severe congestive heart failure","volume":"6","author":"Blake","year":"2000","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jash.2013.05.004_bib47","first-page":"195","article-title":"[comparison of antihypertensive and metabolic effects of lisinopril 20 mg\/hydrochlorothiazide 12.5 mg fixed combination and captopril 50 mg\/hydrochlorothiazide 25 mg fixed combination]","volume":"52","author":"Milon","year":"1997","journal-title":"Therapie"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171113000934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171113000934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T02:20:55Z","timestamp":1539570055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171113000934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1933171113000934"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2013.05.004","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}